Results 201 to 210 of about 164,505 (264)

Guillain–Barre Syndrome With Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation

The Kaohsiung Journal of Medical Sciences, EarlyView.
Chin‐Mu Hsu, Ping‐Hsuan Lin, Chia‐Hsuan Chiu, Hui‐Hua Hsiao   +3 more
wiley   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion. [PDF]

J Hematop
Cook JR, Astbury C, Bosler DS, Molina JC, Rogers HJ, Sobecks RM, Owczarczyk AB.   +6 more
europepmc   +1 more source

Disease–Drug–Drug Interaction of Imatinib in COVID‐19 ARDS: A Pooled Population Pharmacokinetic Analysis

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 583-595, March 2025.
ABSTRACT Prior pharmacokinetic (PK) analysis revealed that increased alpha‐1‐acid glycoprotein (AAG) levels are associated with decreased imatinib unbound fraction in coronavirus disease 2019 (COVID‐19) patients. This study aimed to investigate the PK of total and unbound concentrations of imatinib and the metabolite N‐desmethyl imatinib in ...
Medhat M. Said, Job R. Schippers, Leila Atmowihardjo, Yingxue Li, Mick S. van der Plas, Harm J. Bogaard, Lieuwe D. J. Bos, Ron A. A. Mathôt, Jurjan Aman, Eleonora L. Swart, Imke H. Bartelink   +10 more
wiley   +1 more source

Transcriptomics-based multi-omics approach for optimizing risk stratification in acute myeloid leukemia. [PDF]

Blood Sci
Yang Y, Yan L, Fang J, Liu H, Tan X, Ma Y, Han X, Chen G, Chen Y, Gong D, Tu S, Wen Q, Li J, Zhang X, Zhang C.   +14 more
europepmc   +1 more source

Fixed-time treatment of elderly patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) using hypomethylating agents and venetoclax - a case series. [PDF]

Ann Hematol
Lindemann A, Göckel G, Garcia-Pardillos G.   +2 more
europepmc   +1 more source

Co-option of lineage plasticity as a hallmark of multipotent acute leukemias. [PDF]

Blood Neoplasia
Gutierrez A, Kentsis A.
europepmc   +1 more source

Reciprocal Clonal Dynamics of Independent <i>FLT3</i> D835V-Positive Acute Myeloid Leukemia and Chronic Myeloid Leukemia With Gilteritinib. [PDF]

EJHaem
Osone K, Katagiri S, Chi S, Minami Y, Gotoh A, Akahane D.   +5 more
europepmc   +1 more source

Brain Abscess Following CPX-351 Treatment in a Patient With Acute Myeloid Leukemia. [PDF]

Case Rep Hematol
Yamaga Y, Okazaki S, Sakuma Y, Siraisi D, Nishiyama T.   +4 more
europepmc   +1 more source